期刊文献+

急性冠脉综合征患者血胆红素、纤维蛋白原、脂蛋白(a)的变化及与冠脉病变程度的关系 被引量:9

Changes of serum bilirubin,plasma fibrinogen and serum lipoprotein(a) and association of the severity of coronary artery lesion and them in patients with acute coronary syndromes
下载PDF
导出
摘要 目的:探讨血清胆红素(Bil)、血浆纤维蛋白原(Fib)和血清脂蛋白(a)[Lp(a)]在急性冠脉综合征(ACS)患者中的变化及与冠脉病变程度的关系。方法:选择急性心肌梗死患者(AMI组)30例、不稳定性心绞痛患者(UAP组)38例、稳定性心绞痛患者(SAP组)23例、冠状动脉造影阴性者(对照组)28例,分别测定血清总胆红素(TBil)、直接胆红素(DBil)、间接胆红素(IBil)、血浆Fib和血清Lp(a)的水平,比较各组间有无差别,并分析它们与冠脉病变程度的关系。结果:1与对照组相比,TBil、DBil和IBil在AMI组、UAP组、SAP组均明显降低(P均<0.01),而且AMI组明显低于SAP组(P均<0.05),但与UAP组差异无显著性(P均>0.05),UAP组与SAP组相比,TBil明显降低(P<0.05),而DBil、IBil差异无显著性(P>0.05);AMI组Fib明显高于UAP组、SAP组与对照组(P均<0.01),但UAP组、SAP组和对照组相比Fib差异无显著性(P>0.05);Lp(a)四组间差异无显著性(P>0.05)。23支病变组TBil、DBil、IBil明显低于1支病变组(P均<0.05),与2支病变组差异无显著性(P>0.05);2支病变组DBil明显低于1支病变组(P<0.05),而TBil、IBil差异无显著性(P均>0.05);3支病变组Fib明显高于2支病变组、1支病变组(P均<0.05),而2支病变组与1支病变组差异无显著性(P>0.05);Lp(a)3支病变组、2支病变组、1支病变组组间差异无显著性(P>0.05)。3spearman相关分析显示冠脉狭窄积分与TBil、DBil、IBil呈负相关,与糖尿病史和Fib呈正相关(r分别为-0.311、-0.210、-0.311、0.299、0.335,P值均<0.05)。多元逐步回归分析显示TBil、糖尿病史及Fib对冠脉狭窄积分影响比较大。结论:血清Bil降低、血浆Fib升高与ACS的发生和冠脉病变严重程度密切相关,脂蛋白(a)与ACS以及冠脉病变程度关系可能不大。 Objective:To investigate the changes of serum total bilirubin(TBil), serum direct bilirubin(DBil),serum indirect bilirubin(IBil),plasma fibrinogen(Fib) and serum lipoprotein(a)[ Lp(a)] and association of the severity of coronary artery lesion and them in patients with acute coronary syndromes(ACS). Methods: 30 patients with acute myocardial infarction(AMI group), 38 patients with unstable angina pectoris (UAP group)and 23 patients with stable angina pectoris(SAP group) were studied, and 28 coronary angiography negative subjects were taken as controls(control group). The serum Bil,plasma Fib and serum Lp(a) were measured respectively. The levels of them in 4 groups and association of the severity of coronary artery lesion and them were analyzed. Results: ①Compared with control group, the levels of TBil,DBil and IBil among AMI group,UAP group and SAP group were significantly lower(P0.01), and the levels of them in AMI group were significantly lower than them in SAP group(P0.05), but compared with UAP group, there were no significant difference(P0.05). The levels of TBil in UAP group was significantly lower than it in SAP group(P0.05), but the levels of DBil and IBil were no significant difference(P0.05). The levels of Fib in AMI group was significantly higher than it in UAP group,SAP group and control group(P0.01), but the levels of Fib among UAP group,SAP group and control group were no significant difference(P0.05). The levels of Lp(a) among four groups were no significant difference(P0.05). ②The levels of TBil,DBil and IBil in triple branch lesions group was significantly lower than them in single branch lesion group(P0.05), but compared with double branch lesions group, there were no significant difference(P0.05). The levels of DBil in double branch lesions group was significantly lower than them in single branch lesion group(P0.05), but the levels of TBil and IBil were no significant difference(P0.05). The levels of Fib in triple branch lesions group was significantly higher than them in double branch lesions group and single branch lesion group(P0.05), but the levels of Fib in single branch lesion group and double branch lesions group were no significant difference(P0.05). The levels of Lp(a) among single branch lesion group,double branch lesions group and triple branch lesions group were no significant difference(P0.05). ③Spearman correlation analysis showed: scores of coronary artery lesion were negatively related to the levels of TBil,DBil and IBil, and positively related to history of diabetes mellitus(DM) and the levels of Fib(spearman r:-0.311、-0.210、-0.311、0.299、0.335,P0.05). Stepwise multiple linear regression showed that TBil, history of DM and Fib were associated with scores of coronary artery lesion. Conclusion: The levels of reduced Bil and elevated Fib are closely related with ACS and the severity of coronary artery lesion, but the levels of Lp(a) may be not related with them.
出处 《陕西医学杂志》 CAS 2010年第4期423-427,共5页 Shaanxi Medical Journal
关键词 冠状动脉疾病/病理生理学 胆红素/血液 纤维蛋白原/血液 脂蛋白/血液 Coronary disease/physiopathology Bilirubin/blood Fibrinogen/blood Lipoprotein(a)/blood
  • 相关文献

参考文献9

  • 1Braunwald E,Antman EM,Beasley JW,et al.ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction.A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).J Am Coll Cardiol,2000,36(3):970-1062.
  • 2Schwertner HA,Jackson WG,Tolan G.Association of low serum concentration of bilirubin with increased risk of coronary artery disease.Clin Chem,1994,40(1):18-23.
  • 3陈刚,古孜丽.吾热孜木,刘刚,李国庆,雷建新,戴晓燕,任澎,姚娟,王钊,阿木提.阿不都,穆叶塞.尼加提,米日古丽.阿不都热合曼,阿德尔江.买买提,陈晓阳.血清胆红素水平与冠状动脉病变严重程度相关性分析[J].新疆医科大学学报,2007,30(2):136-138. 被引量:1
  • 4Jameel NM,Frey BM,Frey FJ,et al.Inhibition of secretory phospholipase A(2) enzyme by bilirubin:a new role as endogenous anti-inflammatory molecule.Mol Cell Biochem,2005,276(1-2):219-225.
  • 5Guidelines Subcommittee.1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension.Guidelines Subcommittee.J Hypertens,1999,17(2):151-183.
  • 6Danesh J,Lewington S,Thompson SG,et al.Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality:an individual participant meta-analysis.JAMA,2005,294(14):1799-1809.
  • 7刘梅颜,胡大一,闫丽,刘文红,刘如辉.高水平纤维蛋白原与冠状动脉狭窄严重程度相关性探讨[J].中华内科杂志,2004,43(11):820-823. 被引量:37
  • 8胡泽平,王邦宁,刘敏,骆志刚,陈大年,曹海学.C-反应蛋白、纤维蛋白原和脂蛋白(a)与急性冠脉综合征的相关性[J].安徽医科大学学报,2005,40(2):170-172. 被引量:4
  • 9董平栓,张薇.纤维蛋白原、高敏C反应蛋白与冠心病相关性分析[J].陕西医学杂志,2009,38(3):326-327. 被引量:18

二级参考文献33

  • 1Michela Vischetti , Francesco Zito , Maria Benedetta Donati , Licia Iacoviello. Analysis of gene environment interaction in coronary heart disease: fibrinogen polymor-phisms as an example. Ital Heart J , 2002, 3: 18223.
  • 2Kant JA, Fornace AJ, Saxe D, et al. Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci USA, 19851 82 (8) 2344-2348.
  • 3Fichtlscherer S,Heeschen C,Zeiher AM. Inflammatory markers and coronary artery disease(review). Curt Opin Pharmacol, 2004,4 : 124-131.
  • 4Lowe GD , Rumley A , Mackie IJ. Plasma fibrinogen [J]. Ann Clin Biochem , 2004 ,41:430-440.
  • 5Parmonov AD, Moiseev SV, Fomin VV, et al. Ferritin and other acute phase proteins in various forms of coronary heart disease [J]. Klin Med (Mosk), 2005,56 (2):277-283.
  • 6Biasucci LM. C-reactive protein and secondary prevention of coronary events. Clinica Chemica Acta, 2001,311 (7) : 49-52.
  • 7Ross R.Atherosclerosis is an inflammatory disease.Am Heart J,1999;138(5 Pt 2):S419~20.
  • 8Altieri DC,Mannucci PM,Capitanio AM.Binding of fibrinogen to human monocytes.J Clin Invest,1986;78(4):968~76.
  • 9Seman LJ,DeLuca C,Jenner JL et al.Lipoprotein (a)-cholesterol and coronary heart disease in the framingham heart study.Clin Chem,1999;45(7):1039~46.
  • 10Fuster V,Badimon L,Badimon JJ et al.The pathogenesis of coronary artery disease and the acute coronary syndromes(1).N Engl J Med,1992;326(4):242~50.

共引文献55

同被引文献68

引证文献9

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部